Clinical Trial Update: Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

BA1302 from Shandong Boan Biotechnology Co., Ltd is in Phase 1 testing for advanced solid tumors, with non-small cell lung cancer, pancreatic adenocarcinoma, br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Pancreatic Adenocarcinoma

Drugs mentioned

• BA1302

Snippet

Sponsor: Shandong Boan Biotechnology Co., Ltd | Conditions: Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma | Phase 1 | Status: RECRUITING